BIORA THERAPEUTICS INC - NOTE 7.250%12/0

CUSIP: 74319FAB3

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Debt / NOTE 7.250%12/0
Market price (% of par)
68.43%
Total 13F principal
$129,226,000
Principal change
+$129,226,000
Total reported market value
$93,505,000
Number of holders
5
Value change
+$93,505,000
Number of buys
5

Quarterly Holders Quick Answers

What is CUSIP 74319FAB3?
CUSIP 74319FAB3 identifies 74319FAB3 - BIORA THERAPEUTICS INC - NOTE 7.250%12/0 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of BIORA THERAPEUTICS INC - NOTE 7.250%12/0 as of Q4 2021

As of 31 Dec 2021, BIORA THERAPEUTICS INC - NOTE 7.250%12/0 was held by 5 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $129,226,000 in principal (par value) of the bond. The largest 5 bondholders included Athyrium Capital Management, LP, Davidson Kempner Capital Management LP, HIGHBRIDGE CAPITAL MANAGEMENT LLC, CAMDEN ASSET MANAGEMENT L P /CA, and Context Capital Management, LLC. This page lists 5 institutional bondholders reporting positions for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.